L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study
Paul E. Drawz,Roland Brown,Luca De Nicola,Naohiko Fujii,Francis B. Gabbai,Jennifer J. Gassman,Jiang He,Satoshi Iimuro,James P. Lash,Roberto Minutolo,Robert A. Phillips,Robert A. Phillips,Kyle Rudser,Luis M. Ruilope,Susan Steigerwalt,Raymond R. Townsend,Dawei Xie,Mahboob Rahman +17 more
TL;DR: Prevalence of masked and sustained hypertension was elevated in males, patients with diabetes, participants on four or more antihypertensives, and those with moderate-to-severe proteinuria in patients with CKD.
Journal ArticleDOI
Proteinuria: an underappreciated risk factor in cardiovascular disease.
TL;DR: Changes in renal function produced by hypertension appear to be associated with higher cardiovascular morbidity and mortality, and recent data indicate that even minor derangements of renal function are associated with an increase in cardiovascular risk factors, and promotion of atherosclerosis.
Journal ArticleDOI
Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats.
Rosaura Maeso,Elena Rodrigo,Raquel Muñoz-García,Josefa Navarro-Cid,Luis M. Ruilope,Victoria Cachofeiro,Vicente Lahera +6 more
TL;DR: The effects of losartan on senescent spontaneously hypertensive rats were due not only to its blood-pressure-lowering action but also to the blockade of specific mechanisms derived from angiotensin II type 1 receptor antagonism, which might involve an increase in availability of NO.
Journal ArticleDOI
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke
Alberto Zanchetti,Lisheng Liu,Giuseppe Mancia,Gianfranco Parati,Guido Grassi,Marco Stramba-Badiale,Vincenzo Silani,Grzegorz Bilo,Giovanni Corrao,Antonella Zambon,Lorenza Scotti,Xin-Hua Zhang,Ting Rui Guan,Yuqing Zhang,Xuezhong Zhang,Eivind Berge,Josep Redon,Krzysztof Narkiewicz,Anna F. Dominiczak,Peter M. Nilsson,Margus Viigimaa,Stéphane Laurent,Enrico Agabiti-Rosei,Zhaosu Wu,Dingliang Zhu,Jose L. Rodicio,Luis M. Ruilope,Nieves Martell-Claros,Fernando Pinto,Roland E. Schmieder,Michel Burnier,Maciej Banach,Renata Cifkova,Csaba Farsang,Alexandra Konradi,Irina Lazareva,Yuriy Sirenko,Maria Dorobantu,Arman Postadzhiyan,Rok Accetto,Bojan Jelaković,Dragan Lovic,Athanasios J. Manolis,Philippos Stylianou,Dror Dicker,Gangzhi Wei,Chengbin Xu,Hengge Xie,Antonio Coca,John T. O'Brien,Gary A. Ford +50 more
TL;DR: The ESH-CHL-SHOT trial investigators include Alberto Zanchetti, Lisheng Liu, Giuseppe Mancia, Gianfranco Parati, Guido Grassi, Marco Stramba-Badiale, Vincenzo Silani, Grzegorz Bilo, Giovanni Corrao, Antonella Zambon, Lorenza Scotti, Xinhua Zhang, Ting Rui Guan, Yuqing Zhang, Xuezhong
Journal ArticleDOI
Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study.
Pablo Gomez,Luis M. Ruilope,Vivencio Barrios,Jorge Navarro,Miguel Angel Prieto,Olga Gonzalez,Lucia Guerrero,Miguel Angel Sanchez Zamorano,Claudia Filozof +8 more
TL;DR: It was concluded that patients who have hypertension and visceral obesity and attend primary care present a higher prevalence of metabolic syndrome and RI.